The EU funded project FRINGE has officially started on 1st of May 2019. The project will run for 54 month under the coordination of Dr. Theodossis Theodossiou from the Olso Universitetssykehus HF.
FRINGE is an ambitious project as it sets out to achieve a scientific breakthrough in previously uncharted territory in order to pave the way for a ground-breaking new cancer therapy and potential other applications, some of which may be feasible yet still beyond current imagination.
In order to set FRINGE in motion, scientists from diverse disciplines are set to collaborate:
- Nuclear physicists
- Synthetic chemists from the research and the industry sector
- Nuclear engineers
- Medical physicists
- Quantum chemists
This uncommon mix of disciplines was carefully recruited to fulfil all the requirements of the task at hand, and to overcome the inherently cross-disciplinary challenges in order to maximise the chances of achieving the envisioned breakthroughs and counterbalancing the inherent high risk.